Copyright
©2010 Baishideng.
World J Diabetes. May 15, 2010; 1(2): 36-47
Published online May 15, 2010. doi: 10.4239/wjd.v1.i2.36
Published online May 15, 2010. doi: 10.4239/wjd.v1.i2.36
S No | Method | Comments | Advantages | Disadvantages |
1 | Hyperinsulinemic euglycemic glucose clamp | Gold standard method for quantifying insulin sensitivity | Direct measure of insulin under steady-state conditions | Laborious, involves intra venous infusion of insulin, frequent blood sampling |
2 | Oral glucose tolerance test | Clinically used to detect glucose intolerance | Helps in estimating other surrogate indices | Useful for glucose tolerance but not for IR |
3 | Fasting insulin | Most practical method to measure IR | Detects insulin resistance before clinical disease appears | Lack of standardization of the insulin assay procedure |
4 | Glucose/insulin ratio (G/I ratio) | comparable to insulin sensitivity measured by the FSIVGTTT | Highly sensitive & specific for insulin sensitivity | Does not aptly reveal the physiology of insulin sensitivity |
5 | Insulinogenic index (IGI) | index of β-cell function δI (0-30 min)/δG (0-30 min) | Measure of first-phase insulin response to glucose challenge | Not broadly validated |
6 | Homeostasis model assessment | Assesses inherent β-cell function and insulin sensitivity HOMA-IR = (G × I)/22.5 | Simple, minimally invasive, predicts fasting steady-state G and I levels | Insulin sensitivity in subjects treated with insulin needs further validation |
7 | Quantitative insulin sensitivity check index (QUICKI) | Mathematical transformation of FBG and insulin QUICKI = 1/[log (IμU/mL) + log(G mg/dL)] | Consistent, precise index of insulin sensitivity, minimally invasive | Normal range to be established for each laboratory due to significant inter laboratory variations in insulin assay |
8 | Minimal model analysis of frequently sampled intravenous glucose tolerance test | Indirect measure of insulin sensitivity/resistance | Analysis using the computer program MINMOD | Multiple blood sampling |
9 | Glucose insulin (GI) product | Index of whole-body insulin sensitivity | ||
10 | Fasting insulin resistance index (FIRI) | (fasting G × fasting I)/25 |
- Citation: Singh B, Saxena A. Surrogate markers of insulin resistance: A review. World J Diabetes 2010; 1(2): 36-47
- URL: https://www.wjgnet.com/1948-9358/full/v1/i2/36.htm
- DOI: https://dx.doi.org/10.4239/wjd.v1.i2.36